These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34434239)

  • 1. Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice.
    Zhu M; Hua T; Ouyang T; Qian H; Yu B
    Stem Cells Int; 2021; 2021():6546780. PubMed ID: 34434239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis.
    Liu P; Qian Y; Liu X; Zhu X; Zhang X; Lv Y; Xiang J
    Front Immunol; 2022; 13():1096402. PubMed ID: 36685534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.
    Hu C; Zhao L; Duan J; Li L
    J Cell Mol Med; 2019 Mar; 23(3):1657-1670. PubMed ID: 30635966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell therapy for liver fibrosis/cirrhosis.
    Cao Y; Ji C; Lu L
    Ann Transl Med; 2020 Apr; 8(8):562. PubMed ID: 32775363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.
    Eom YW; Kim G; Baik SK
    World J Gastroenterol; 2015 Sep; 21(36):10253-61. PubMed ID: 26420953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell therapy for liver fibrosis.
    Eom YW; Shim KY; Baik SK
    Korean J Intern Med; 2015 Sep; 30(5):580-9. PubMed ID: 26354051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.
    Guo Y; Chen B; Chen LJ; Zhang CF; Xiang C
    J Zhejiang Univ Sci B; 2016 Nov.; 17(11):831-841. PubMed ID: 27819130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
    Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
    Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis
    Yin F; Wang WY; Jiang WH
    World J Stem Cells; 2019 Aug; 11(8):548-564. PubMed ID: 31523373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats.
    Yu Y; Lu L; Qian X; Chen N; Yao A; Pu L; Zhang F; Li X; Kong L; Sun B; Wang X
    Stem Cells Dev; 2010 Jun; 19(6):903-14. PubMed ID: 20025519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mesenchymal stem cells in liver injury.
    Sun H; Shi C; Ye Z; Yao B; Li C; Wang X; Qian Q
    Cell Biol Int; 2022 Apr; 46(4):501-511. PubMed ID: 34882906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Umbilical cord mesenchymal stem cells and their association with liver fibrosis].
    Tuo L; Zeng WZ; Xue HL; Wu XL
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):65-68. PubMed ID: 28297787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
    Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
    Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.
    Ewida SF; Abdou AG; El-Rasol Elhosary AA; El-Ghane Metawe SA
    Appl Immunohistochem Mol Morphol; 2017; 25(10):736-745. PubMed ID: 27153445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.
    Berardis S; Dwisthi Sattwika P; Najimi M; Sokal EM
    World J Gastroenterol; 2015 Jan; 21(3):742-58. PubMed ID: 25624709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
    Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
    J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases.
    Zheng W; Yang Y; Sequeira RC; Bishop CE; Atala A; Gu Z; Zhao W
    Curr Stem Cell Res Ther; 2019; 14(5):442-452. PubMed ID: 30854976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside.
    Chen L; Zhang N; Huang Y; Zhang Q; Fang Y; Fu J; Yuan Y; Chen L; Chen X; Xu Z; Li Y; Izawa H; Xiang C
    Stem Cell Rev Rep; 2023 Oct; 19(7):2192-2224. PubMed ID: 37498509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal Stem Cell-Dependent Modulation of Liver Diseases.
    Gazdic M; Arsenijevic A; Markovic BS; Volarevic A; Dimova I; Djonov V; Arsenijevic N; Stojkovic M; Volarevic V
    Int J Biol Sci; 2017; 13(9):1109-1117. PubMed ID: 29104502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury.
    Mardpour S; Hassani SN; Mardpour S; Sayahpour F; Vosough M; Ai J; Aghdami N; Hamidieh AA; Baharvand H
    J Cell Physiol; 2018 Dec; 233(12):9330-9344. PubMed ID: 29266258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.